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Abstract 
As people get older, they are at increased risks of increased co-morbidities. As such elderly 
patients maybe prescribed many medications to manage these multiple medical conditions. An 
attempt to treat one medical condition may result in complications or drug interactions. With 
hospitalization, clinicians tend to prescribe more medications to the elderly. This becomes 
complex, and sometimes lead to non-compliance, improper administration and negative effects 
on the body. Clinicians do not usually focus on medication review. Elderly may continue to take 
these medications indefinitely if they are not reviewed for effectiveness or appropriateness. The 
case study presented a patient with multiple medications with possible adverse drug reactions. 
This case report aims to examine polypharmacy, consequences of polypharmacy and the 
importance of medication review in reducing negative consequences of polypharmacy. 
Medication review in elderly patients is important in preventing drug adverse effects, improves 
of prescription quality and patient outcomes. A literature review was conducted to review 
polypharmacy, the process, benefits and tools used in medication review in older population 
according to National Health Service (NHS) and National Institute for Health and Care 
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Background 
Polypharmacy is defined as prescribing at least four to five medications (Avery, 2011). 
Polypharmacy can also be classified as “taking medications with no appropriate indication, use 
of therapeutic equivalents to treat same illness, use of interactive medications, use of 
inappropriate dosage and use of other medications to treat adverse drug reactions” (Farrell, 
Shamji, Monahan, & Merkley, 2013). This includes prescription and over-the-counter 
medications. In the United States, the incidence of polypharmacy is increasing in the geriatric 
population. According to Pretorius and colleagues, older adults who are 65 years and older 
consume about 30% of all prescription medications with a total cost of about $3 billion dollars in 
annual prescription (Pretorius, Gataric, Swedlund &Miller, 2013). As people get older, the 
prevalence of chronic diseases increases. Drug therapy is necessary in the management of these 
diseases and the use of multiple medications makes drug regimen complex and increases risk for 
complications such as polypharmacy.  
 With increasing age, many physiological changes occur which affect pharmacokinetics 
of drugs in the elderly (Cope, 2013). This includes changes in absorption, distribution, 
metabolism and excretion of drugs. Absorption of medication decreases with age due to decrease 
in the intestinal epithelial surfaces (Pretorius et al, 2013). This increases drug concentration in 
the body. Distribution of drugs depends on the water, protein and fat content of the body. Body 
fat increases with age and muscle mass decreases. Drugs tend to remain longer in the body with 
these changes; adding the potential of drug overdose (Pretorius et al, 2013). Drug metabolism 
occurs in the liver. Supply of blood decreases with age with the potential increase drug 
concentration. Decrease renal function also poses risk for increased drug toxicities.  
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 There is also high risk of drug-drug interaction and adverse drug events with 
polypharmacy, including falls, gastrointestinal bleeds, cognitive changes, constipation 
(Kaufman, 2015; Pretorius et al, 2013). More and more people are being re-admitted due to 
hospital as a result adverse drug reactions. According National Health Service, Scotland (NHS, 
2012), there is little guidance to assist providers with balancing evidence based practice 
recommendations when managing multiple co-morbidities to obtain better patient outcomes. 
Medication review is an important process used in the management of polypharmacy. 
Bergman-Evans (2012) defines medication review as the examination of patient’s 
medication with the objective of reaching an agreement with patient regarding treatment and 
optimizing positive impact of medications and reducing negative outcomes. When doing 
medication review, the individual client should be taken into consideration. Tools that may be 
used for medication review include; NO TEARS, BEER criteria, STOPP criteria and START 
criteria (All Wales Medicine Strategy Group, 2015, American Geriatric Society, 2015 & 
Bergman-Evans, 2012). The purpose of these tools is to improve care of older adults by reducing 
potentially inappropriate medication, monitor drug use and to decrease adverse drug reactions. 
Case Report 
History of present illnesses: EE is an 87 year old Caucasian female who is seen today for 
follow up after three days hospitalization for UTI and fatigue. Patient complained of fatigue and 
dizziness. Fatigue is worst in the morning upon waking up. Stated she sleeps through the night. 
Denies mood changes. Patient feels dizzy when changing position. Denies lightheadedness. 
Denies headaches, fever or chills. Denies shortness of breath.  Denies dysuria, urinary urgency or 
frequency. Patient is on Nitrofurantoin 100mg, has 3 more days of antibiotic therapy. Patient 
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stated she feels better, has been sleeping well. Patient is alert and oriented with intermittent 
forgetfulness. 
Medications:  
Donepezil 5mg po daily 
Fluticasone propionate and Salmeterol 250/50, 1 puff twice daily 
Losartan 50mg po daily 
Metoprolol 50mg twice daily 
Gabapentin 300 mg po three times daily 
Paroxetine 20 mg po daily 
Quetiapine 200mg po twice daily 
Insulin glargine 30 units SQ at bedtime 
Nitrofurantoin ER 100mg po twice daily x 7 days (3 days left) 
Multivitamin po daily 
Iron sulfate 325mg po twice daily 
Allergies: NKDA  
PMH: Dementia, Diabetes, COPD, Anemia, hypertension, depression and neuropathy.  
Family history: Familial history of hypertension and heart disease. Patient unable to state which 
family member was affected. 
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Social History: Lives in an assisted living. Daughter assists with medication set-up. Never 
smoked, used alcohol or illicit drugs 
ROS: 
Constitutional: Denies any fever or chills, reported fatigue 
Cardiovascular: Denies chest pain or palpitations  
Respiratory: Mild shortness of breath with activity, has history of COPD  
GI: Denies decreased in appetite, constipation, nausea, vomiting, diarrhea or abdominal pain 
GU: Denies dysuria, urgency or frequency. Currently on antibiotic for urinary tract infection  
Musculoskeletal: Denies muscle or joint pain 
Neurological: Denies headaches or lightheadedness. Denies numbness or tingling 
Skin: Denies rashes or skin lesions 
Psychosocial: Denies mood changes. Denies sleep disturbance 
 
Physical Examination: 
VS: BP 88/40, HR 50, Temp 98.6, RR 24, FSBS morning 107 
General appearance: Alert and oriented, in no acute distress. Well-groomed and engages in 
conversation.  
HEENT: Head Normocephalic, atraumatic. Wears glasses. Pupils equal and reactive to light.   
Neck: Supple, with normal ROM, no thyroidomegaly. 
CV: Regular rate and rhythm, S1, S2 no murmurs, gallops, or rubs.  No JVD. 2+ bilateral pedal 
pulses 
 POLYPHARMACY AND MEDICATION REVIEW IN THE ELDERLY                                                                      8 
 
Respiratory: Breathing effortless. Lung sounds clear to auscultation in all lung fields no 
wheezes, rhonchi, or rales.  
GI: Soft and non-distended. Positive bowel sounds in all quadrants. No tenderness with 
palpation, no organomegaly.  
Skin: warm and dry, no lesions  
Extremities: Trace edema to bilateral lower extremities, no tenderness 
 
Differential Diagnosis: 
Urinary tract infection, Fatigue, Hypotension, Diabetes, orthostatic hypotension, polypharmacy, 
Anemia, hypothyroidism 
Labs/Imaging 
-CBC, BMP, TSH studies  
-EKG 
 
Management and plan 
 
1 Hypotension, likely due to use of hypertensive medications. Currently on Losartan 50 mg and 
Metoprolol 50 mg twice daily.  
Plan: continue Losartan 50 mg daily; Discontinue Metoprolol, start Metoprolol ER 50 mg daily; 
Check orthostatic blood pressure x 3 days. Update provider on any drop in BP from sitting to 
standing; avoid changing positions abruptly 
2 Fatigue, probably due to anemia vs current UTI. Hemoglobin stable, denies symptoms of UTI 
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Plan: Continue Iron supplements, return to clinic if symptoms persist 
3 Urinary tract infections, on Nitrofurantoin, has three more days of antibiotic 
Plan; complete antibiotic regimen 
4 Diabetes, stable 
Plan, continue Lantus 
5 Polypharmacy has multiple co-morbidities and takes 11 different prescription medications 
daily. Review medications and discontinue potentially inappropriate medications 
Plan; decrease Gabapentin from 300mg to 100 mg three times daily 
Literature Review 
In this literature review, I will be incorporating a case report of an 87 year old female 
with multiple co-morbidities who was having potential adverse drug reaction from 
polypharmacy. During her follow-up appointment she had hypotension which increases her risk 
for falls. Medication review was done and dose reduction done. The aim of this literature review 
is to describe polypharmacy, review evidence-based recommendations on medication review, the 
process of medication review and tools used to carry out medication review in the elderly 
population. 
An online search was done using PubMed using keys words “Polypharmacy”, “older 
adults”, “Medication review” and “Medication reconciliation” yielded 95 articles. Search was 
narrowed to RCT in the last six years, 5 articles were retrieved that were relevant to case study 
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Another search was done using CINAHL database using key words “Polypharmacy”, 
“Older adults”, “Medication review” and “Medication reconciliation”. 4162 articles were 
retrieved. Search was narrowed to 2010-2016, peer reviewed, English language, age 65 and 
older, and Medline excluded. Fifteen articles were retrieved that were relevant to case study. 
Medication Review Process 
 Medication review is an important factor in determining medication prescription, safety 
and compliance. Medication review should be a collaborative approach between the provider, 
pharmacist and the patient. According to National Institute for Health Care Excellence (NICE, 
2014), medication review should include the following: 
 Medication history taking into consideration new and existing medications 
 Is the medication appropriate for the age group? 
 Complexity of medication regimen, can the regimen be simplified to promote 
adherence? 
 What are the barriers to medication adherence? 
 Medication pharmacokinetics 
 Is the patient experiencing adverse drug events including geriatric syndromes? 
Medication regimen should be adjusted based on the findings of medication 
review. 
According to NHS guideline (2012), there are three levels in medication review. Level 1 
involves doing a face to face review of medication with the patient. This involves checking 
appropriateness, cost, adherence and potential side effects of the medication. Level 2 involves 
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treatment review which is if medication is yielding good outcomes. Level 3 is clinical 
medication review and making recommendations as needed to reduce inappropriate medications. 
Benefits of Medication Review 
Prescribing a drug regimen using evidence based practice is important in managing 
complex medical conditions. However there are many drug-related problems which may result 
from this regimen including hospital readmission from adverse drug reactions. These problems 
can be prevented by reviewing patients’ medication upon discharge from the hospital. 
Medication review will identify clinically inappropriate medications, assist with monitoring of 
necessary labs, improve communication between providers and also identifying which 
medications may be contributing to adverse reaction (Hellstrom, Bondesson, Hoglund, 
Holmdahl, & Rickhag, 2010). 
Studies done on medication review and assessment describe a variety of interventions and 
outcomes including hospitalization, morbidity, mortality, and quality of life. Mckean, Pillans & 
Scott (2015) did a pilot study on medication review and deprescribing in hospitalized patients 
receiving multiple medications. The physicians used pharmacist reconciled medication list and 
formal sit-down meetings to do the medication review. The authors concluded that a standardized 
method of medication may significantly reduce the number of medications. In this study, one in 
four medications was deprescribed prior to hospital discharge. 
Another study done by Hellstrom et al, 2011, investigated the impact of Lund integrated 
medicines management (LIMM) model on medication appropriateness and drug-related hospital 
revisits in elderly patients within three months of discharge. The LIMM model is a systematic 
approach that optimizes and individualizes drug treatment in hospitalized patients upon 
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admission, during hospitalization and at discharge. The authors found out that this model is 
important in decreasing the amount of inappropriate medications taken by hospitalized elderly 
patients. 
Lampela, Hartikainen, Sulkava & Huupponen (2010) did a population-based intervention 
study to investigate the impact of medication assessment as part of a comprehensive geriatric 
assessment (CGA) on drug use over a 1-year period. The participants in this study were home-
dwelling, greater than 75 years and took two to ten medications daily. Interventions included 
medication adjustment, evaluation of indication for medication use, clinical evaluation of 
patients (cognition, mood, orthostatic reactions) and monitoring of routine labs. At the end of the 
review, some medications were adjusted (especially the drugs affecting central nervous systems) 
inappropriate medications were discontinued and new medications started for new diagnoses. 
Medication Review Tools 
A BEERs criterion is a medication review tool implemented by the American Geriatric 
Society (2015) to assist clinicians with safe prescription in the elderly population. This tool 
enables clinicians to prescribe medications (1) based on the patient’s diagnosis and (2) 
independent of the patient’s diagnosis. According to the BEERS criteria the following classes of 
medications should be avoided in elderly patients as they have the potential of causing adverse 
drug reactions even when normal doses are taken. This includes Benzodiazepines, digoxin, first 
generation antihistamines, tricyclic antidepressants, Megestrol, and some hypoglycemic agents. 
Screening tool for older person’s potentially inappropriate prescription (STOPP) and 
screening tools to alert doctors to right treatment (START) are tools used to avoid medications 
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that are potentially inappropriate and to identify medications use where risk outweighs benefits. 
(Pretorius et al, 2013).  
 Graziano et al (2014) did carry out a project to assess appropriate medication use in 
elderly with complex medical conditions who have limited life expectancy, functionally impaired 
and have geriatric syndromes. The purpose of the project was to come out with recommendations 
that will guide providers do quality prescription in this population of adults. The tool used for 
this project criteria to assess appropriate medications use among elderly complex patients 
(CRIME). The authors came out with 19 recommendations for medication management in 
patients with co-morbidities including diabetes, hypertension, congestive heart failure coronary 
artery disease and atrial fibrillation. 
Learning Points 
 Polypharmacy poses a challenge to both providers and patients. There should be 
communication between providers, the pharmacist and the patient to prevent potential 
adverse drug events. 
 The provider should be aware of potentially inappropriate drugs in the elderly population. 
This can be made possible by making use of medication review tools and evidence-based 
practice guidelines. 
 Medication review should be done with each office visit or hospitalization. Patients 
should be encouraged to bring a current list of all their medications, prescription and 
over- the- counter medications. 
 For patients with complex medication regimen, medication review should be done and 
those medications that are not therapeutic be discontinued.  
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 Medication review prevents serious complications, easier and safer medication regimen 
and may also reduce health care spending by reducing re-hospitalization. 
 
Conclusion 
Polypharmacy is significant problem affecting the elderly population. Consequences of 
polypharmacy include geriatric syndromes, poor adherence, re-hospitalization, mortality and 
increase cost of health care spending. Careful medication assessment and review is important to 
prevent some of these complications. There are a variety of tools to assist with medication 
review including BEERs, STOPP and START. Medication review has been shown to be effective 
reducing the number of inappropriate medications, reduce re-hospitalization and adverse drug 
events. While medication review may be time consuming, in order to improve quality of life in 
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